JPMorgan upgrades Procter & Gamble, says consumer staples stock could be an earnings compounder

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Business News News

Business Business Latest News,Business Business Headlines

The firm upgraded the stock to overweight from neutral and raised its price target.

Investors should buy Procter & Gamble shares now, according to JPMorgan. Analyst Andrea Teixeira upgraded the Tide and Pampers parent to overweight from neutral. She also raised her price target by $5 to $155, which implies the stock could advance 10.8% from Thursday's close. Teixeira said investors should try to get ahead of what she sees as a likely inflection point in its fiscal 2023 fourth quarter.

2% following the upgrade in Friday premarket trading. The stock is down 7.7% this year after falling 7.4% in 2022, meaning it's now underperforming the S & P 500 after outperforming last year. PG .SPX 5Y mountain Comparison chart between PG and S & P 500 The upgrade marks an undoing of last year's downgrade, when the stock was underperforming large cap, multinational peers in the home and personal care products and beverages industries.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

JPMorgan downgrades Marqeta, cites muted 2023 growth outlook for the payments companyJPMorgan lowered its rating for Marqeta to neutral from overweight. It also slashed its price target to $6 from $9. Simonkhalaf $MQ
Source: CNBC - 🏆 12. / 72 Read more »